(Casper 2007; Gay and Dousset 2005; Liebeskind, et al. 1996; Powell, et al. 1996; Powell
and Sandholz 2012) that is distinct from markets and hierarchies, grounded in trust and …

This article traces the trajectory of biotechnology firms, clusters and collaborations in
Australia between 2003 and 2014. Combining descriptive analyses, network visualizations …

This paper aims at developing a tentative guideline for managers of biotech firms on how to
form and design network ties in biotechnology industries by integrating the findings from the …

Competitive advantage in the biotech industry depends on several key factors: the existence
of vibrant academic institutions (Kenney 1986), venture capital and other forms of risk …

In the dense field of cluster research, it is challenging to come up with a new perspective on
the topic. Yet Sarah Giest's recent publication, The Capacity to Innovate, does precisely that …

This paper examines the organizational arrangements used by New Biotechnology Firms
(NBFs) to source scientific knowledge. Using data from two highly successful NBFs, the …

" In The Capacity to Innovate, Sarah Giest provides insight into the collaborative and
absorptive capacities needed to provide public support to local innovation through cluster …

Survival and growth of firms depends on their relationships to other organisations, including
key suppliers, customers, supporters and competitors. This study compares geographic …

Regional technology clusters are an important source of economic development, yet in
biotechnology few successful clusters exist. Previous research links successful clusters to …

This volume analyzes the dynamics and interactive processes among the players
(individuals, institutions, and organizations/firms) that have constituted and legitimized the …